Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
Basic protocol for transepithelial nasal potential difference measurementsDaniel Schüler, Isabelle Sermet-Gaudelus, Michael Wilschanski, et al.
Therapeutic Drug Monitoring|March 17, 2016
Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific CommitteeChristoph Seger, Maria Shipkova, Uwe Christians, et al.
Pharmacogenomics|April 21, 2015
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifenMarina Venzon Antunes, Vanessa de Oliveira, Suziane Raymundo, et al.
Therapeutic Drug Monitoring|June 11, 2020
Measuring Intracellular Concentrations of Calcineurin Inhibitors: Expert Consensus from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Expert PanelFlorian Lemaitre, Nils T Vethe, Antonio D'Avolio, et al.
Clinical Biochemistry|December 27, 2016
The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian studyFlorence Van Obbergh, Laurent Knoops, Timothy Devos, et al.
Therapeutic Drug Monitoring|April 9, 2015
Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen BiotransformationMarina V Antunes, Tatiana Aparecida da Fontoura Timm, Vanessa de Oliveira, et al.
Talanta|December 6, 2014
Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapyMarina Venzon Antunes, Suziane Raymundo, Vanessa de Oliveira, et al.
Blood Pressure|July 2, 2019
Predictors of blood pressure control in patients with resistant hypertension after intensive management in two expert centres: the Brussels-Torino experienceMarco Pappaccogli, Silvia Di Monaco, Coralie Georges, et al.
Therapeutic Drug Monitoring|January 30, 2009
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conferencePierre Wallemacq, Victor W Armstrong, Merce Brunet, et al.
The Journal of Antimicrobial Chemotherapy|August 26, 2022
Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medicationsPerrin Ngougni Pokem, Peter Matzneller, Steven Vervaeke, et al.
Pageof 14